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Abstract
In the present study, the effect of long-term fructose feeding on skeletal muscle mitochondrial energetics was investigated. Measurements
in isolated tissue were coupled with the determination of whole-body energy expenditure and insulin sensitivity. A significant increase in
plasma NEFA, as well as in skeletal muscle TAG and ceramide, was found in fructose-fed rats compared with the controls, together with a
significantly higher plasma insulin response to a glucose load, while no significant variation in plasma glucose levels was found. Signifi-
cantly lower RMR values were found in fructose-fed rats starting from week 4 of the dietary treatment. Skeletal muscle mitochondrial mass
and degree of coupling were found to be significantly higher in fructose-fed rats compared with the controls. Significantly higher lipid
peroxidation was found in fructose-fed rats, together with a significant decrease in superoxide dismutase activity. Phosphorylated Akt
levels normalised to plasma insulin levels were significantly lower in fructose-fed rats compared with the controls. In conclusion, a fruc-
tose-rich diet has a deep impact on a metabolically relevant tissue such as skeletal muscle. In this tissue, the consequences of high fructose
feeding are altered glucose tolerance, elevated mitochondrial biogenesis and increased mitochondrial coupling. This latter modification
could have a detrimental metabolic effect by causing oxidative stress and energy sparing that contribute to the high metabolic efficiency
of fructose-fed rats.
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There is considerable evidence suggesting that in human
subjects, elevated intake of sugar-sweetened beverages or
added sugars in the form of sucrose and/or fructose is
associated with increased body weight, the presence of
unfavourable lipid levels, insulin resistance, fatty liver, type 2
diabetes, CVD and the metabolic syndrome(1). Concerning
the specific effects of the monosaccharide fructose on com-
ponents of the metabolic syndrome, authors of recent reviews
have concluded that high fructose intakes have substantial,
even profound, deleterious metabolic consequences that
possibly predispose individuals to chronic conditions such
as type 2 diabetes and CVD(2,3).
It has been previously shown that adult sedentary rats fed a
high-fructose diet for 8 weeks exhibit hepatic insulin resist-
ance, increased lipogenesis and lipid deposition(4), in agree-
ment with previous findings(5–8) and with the fact that about
90 % of fructose coming from the diet is metabolised in the
liver(2). Increased hepatic lipid synthesis implies higher lipid
circulation that could influence other tissues, such as skeletal
muscle, and have a deep impact on whole-body metabolic
homeostasis. Several data in the literature have underlined a
potential link between insulin resistance and mitochondrial
derangement in the skeletal muscle of human and animal
models(9–11), although this notion is challenged by several
findings showing no mitochondrial defect with insulin resist-
ance(12–17). On the basis of these considerations, the effect
of long-term fructose feeding on skeletal muscle mitochon-
drial energetics was investigated. To this end, mitochondrial
mass, oxidative capacity and efficiency in skeletal muscle
were assessed. Measurements in isolated tissue were coupled
with the determination of whole-body RMR and glucose
tolerance.
Research methods and procedures
Male Sprague–Dawley rats (Charles River) of 90 d of age were
caged singly in a temperature-controlled room (23 ^ 18C)
with a 12 h light–12 h dark cycle (06.30–18.30 hours) and
divided into two groups with the same initial body weight
that were fed a high-fructose or control diet (Mucedola
4RF21; Settimo Milanese) for 8 weeks. The composition of
the two diets is given in Tables 1 and 2. Treatment, housing
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and killing of animals met the guidelines set by the Italian
Health Ministry. All experimental procedures involving
animals were approved by ‘Comitato etico-scientifico per la
sperimentazione animale’ of the University ‘Federico II’
of Naples.
At the end of the experimental period, the glucose tolerance
test was carried out. Then, the animals were killed by decapi-
tation, the skeletal muscle was harvested and the carcasses
were used for body composition determination.
RMR
At the beginning and after 2, 4 6 and 8 weeks of the dietary
treatment, VO2 of the rats was recorded with a monitoring
system (Panlab s.r.l.) composed of a four-chamber indirect
open-circuit calorimeter, designed for the continuous moni-
toring of up to four rats simultaneously. Measurements
were performed every 15 min for 3 min in each cage. Food
was withdrawn at 07.00 hours and mean values of a 2 h
period (13.00–15.00 hours) were taken as an indicative of
post-absorptive RMR.
Glucose tolerance test and plasma NEFA
Rats were fasted for 6 h from 08.00 hours. A point 0 sample
was obtained from venous blood from a small tail clip and
then glucose (2 g/kg body weight) was injected intraperitone-
ally. Blood samples were collected after 20, 40, 60, 90, 120 and
150 min. The blood samples were centrifuged at 1400 gav for
8 min at 48C. Plasma was removed and stored at 2208C until
used for determination of substrates and hormones. Plasma
glucose concentration was measured by the colorimetric enzy-
matic method (Pokler Italia). Plasma insulin concentration was
measured using an ELISA kit (Mercodia AB) in a single assay
to remove inter-assay variations.
Plasma NEFA concentrations were measured by the colori-
metric enzymatic method using a commercial kit (Randox
Laboratories Limited).
Body and skeletal muscle composition
Guts were cleaned of undigested food and the carcasses were
then autoclaved. After dilution (1:2 in distilled water) and
subsequent homogenisation of the carcasses with a Polytron
homogeniser (Kinematica), the resulting homogenates were
frozen at 2208C until the day of measurements. Duplicate
samples of the homogenised carcasses were analysed for
energy content by bomb calorimetry. To take into account
the energy content of the harvested skeletal muscle, tissue
samples were dried, the energy content was then measured
with the bomb calorimeter and added to the body energy con-
tent. Total body and skeletal muscle lipid contents were
measured by the Folch extraction method(18). Total body pro-
tein content was determined using a formula relating total
energy value of the carcass, energy derived from fat and
energy derived from protein(19); the energy values for body
fat and protein were taken as 39·2 and 23·5 kJ/g, respectively(20).
Skeletal muscle TAG and cholesterol were measured by the col-
orimetric enzymatic method using commercial kits (SGM Italia),
phospholipids were obtained by subtracting TAG and choles-
terol contents from the total lipid content and glycogen was
assessed by the direct enzymatic procedure(21). Skeletal
muscle ceramide content was evaluated by ELISA(22) using
ninety-six-well Polysorp plates (Nunc). In brief, skeletal muscle
lipids (70ml in methanol) were adsorbed to the well bottoms
overnight at 48C. The plates were blocked with 10 mM-PBS,
140 mM-NaCl and 0·1 % Tween (pH 7·4) supplemented with
1 % bovine serum albumin (BSA) for 1 h at 378C. The plates
were then washed three times with 10 mM-PBS, 140 mM-NaCl
and 0·05 % Tween (pH 7·4) (Tween–PBS), and incubated with
a monoclonal anti-ceramide antibody (2mg/ml) for 1 h at 378C.
Table 1. Composition of the experimental diets
Control diet Fructose diet
Components (g/100 g)
Standard chow 100·0 50·5
Sunflower oil 1·5
Casein 9·2
Alphacel 9·8
Fructose 20·4
Water 6·4
AIN-76 mineral mix* 1·6
AIN-76 vitamin mix† 0·4
Choline 0·1
Met 0·1
Gross energy density (kJ/g) 17·2 17·2
Metabolisable energy density (kJ/g)‡ 11·1 11·1
Protein (J/100 J) 29·0 29·0
Lipids (J/100 J) 10·6 10·6
Carbohydrates (J/100 J) 60·4 60·4
Fructose – 30·0
Starch 45·3 22·8
Sugars 15·1 7·6
AIN, American Institute of Nutrition.
* AIN, 1977.
† AIN, 1980.
‡ Estimated by computation using values (kJ/g) for energy content as follows:
protein 16·736, lipid 37·656 and carbohydrate 16·736.
Table 2. Micronutrient composition of the experimental diets
Control diet Fructose diet
Thiamin (mg/100 g) 1·72 1·11
Riboflavin (mg/100 g) 1·52 1·01
Pyridoxine (mg/100 g) 1·07 0·82
Niacin (mg/100 g) 2·5 2·5
Calcium pantothenate (mg/100 g) 2·5 1·9
Folic acid (mg/100 g) 0·23 0·20
Biotin (mg/100 g) 0·04 0·03
Vitamin B12 (mg/100 g) 0·30 0·40
Vitamin A palmitate (mg/100 g) 0.27 0.43
Vitamin E (mg/100 g) 5·2 6·4
Vitamin D3, cholecalciferol (mg/100 g) 2.6 3.1
Vitamin K (mg/100 g) 0·32 0·22
Calcium phosphate (mg/100 g) 916·3 1262·7
NaCl (mg/100 g) 361·8 301·1
K (mg/100 g) 833·5 756·0
Mg (mg/100 g) 198 138
Mn (mg/100 g) 8·6 9·9
Fe (mg/100 g) 48 34
Zn (mg/100 g) 10·3 7·8
Cu (g/100 g) 2·57 1·78
I (mg/100 g) 0·1 0·07
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After three washings in Tween–PBS, peroxidase-conjugated
goat anti-mouse IgM (1:5000 dilution) was incubated with
the plates for 1 h at 378C. After four washings in Tween–PBS,
the wells were incubated with 100ml of a colour development
solution (20 mg o-phenylenediamine dihydrochloride in 50 ml
of 70 mM-Na2HPO4, 30 mM-citric acid, pH 5, supplemented
with 120ml of 3 % H2O2). After 15 min at 378C, the reaction
was stopped by the addition of 50ml of 2·5 M-H2SO4 and
absorbance was measured at 492 nm. All tests were done in
triplicate. Immunoreactivity was normalised to initial tissue
weight. Negative control reactions included the omission of
the primary antibody.
Metabolisable energy intake was determined as detailed pre-
viously(23), by subtracting the energy measured in the faeces
and urine from the gross energy intake, determined from
daily food consumption and gross energy density of the diet.
Preparation of skeletal muscle isolated mitochondria
and measurements of mitochondrial oxidative capacities,
degree of coupling and uncoupling effect of fatty acids
Hind leg muscles were rapidly removed and used for
the preparation of isolated mitochondria. Hind leg muscles
were freed of excess connective tissue, finely minced,
washed in a medium containing 100 mM-KCl, 50 mM-Tris, pH
7·5, 5 mM-MgCl2, 1 mM-EDTA, 5 mM-ethylene glycol tetraacetic
acid and 0·1 % (w/v) fatty acid-free BSA, and treated with
protease nagarse (1mg/g) for 4 min. Tissue fragments were
then homogenised with the above medium (1:8, w/v) at
500 rpm (4 strokes/min). Aliquots of the homogenate were
withdrawn for measurements of state 3 mitochondrial respir-
ation, while the rest was centrifuged at 3000 gav for 10 min,
the resulting supernatant was rapidly discarded and the
pellet was resuspended and centrifuged at 500 gav for
10 min. The supernatant was then centrifuged at 3000 gav for
10 min, the pellet was washed once and resuspended in a
suspension medium (250 mM-sucrose, 50 mM-Tris, pH 7·5 and
0·1 % fatty acid-free BSA).
Oxygenconsumptionratewasmeasuredpolarographicallywith
a Clark-type electrode (Yellow Springs Instruments) in a 3ml glass
cell at 308C. Skeletalmusclehomogenatesor isolatedmitochondria
were incubated in a medium containing 30mM-KCl, 6mM-MgCl2,
75mM-sucrose, 1mM-EDTA, 20mM-KH2PO4, pH 7·0, and 0·1%
(w/v) fatty acid-free BSA, pH 7·0. The substrates used were
10mM-succinate þ 3·8mM-rotenone, 10mM-glutamate þ 2·5mM-
malate, 40mM-palmitoyl-coenzyme A þ 2mM-carnitine þ 2·5
mM-malate, 40mM-palmitoyl-carnitine þ 2·5mM-malate or
10mM-pyruvate þ 2·5mM-malate. State 3 oxygen consumption
was measured in the presence of 0·3mM-ADP.
The degree of coupling (q) was determined in skeletal
muscle mitochondria by applying equation 11 by Cairns
et al.(24):
q ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
12 ðJ oÞsh=ðJ oÞunc
p
;
where (Jo)sh represents the oxygen consumption rate in the
presence of oligomycin that inhibits ATP synthase and
(Jo)unc is the uncoupled rate of oxygen consumption induced
by trifluorocarbonylcyanide phenylhydrazone (FCCP), which
dissipates the transmitochondrial proton gradient. (Jo)sh and
(Jo)unc were measured as above using succinate 10 mM þ
rotenone 3·75mM in the presence of oligomycin (2mg/ml) or
FCCP (1mM), respectively, both in the absence and presence
of palmitate at a concentration of 45mM.
The uncoupling effect of the fatty acid palmitate was
assessed by measuring the mitochondrial membrane potential
before and after the addition of increasing concentrations of
palmitate. Mitochondrial membrane potential recordings were
performed with safranin O using a JASCO dual-wavelength
spectrophotometer (511–533 nm). Measurements were made
at 308C in a medium containing 30 mM-LiCl, 6 mM-MgCl2,
75 mM-sucrose, 1 mM-EDTA, 20 mM-Tris-PO4, pH 7·0, and 0·1 %
(w/v) fatty acid-free BSA, pH 7·0, in the presence of suc-
cinate (10 mM), rotenone (3·75mM), oligomycin (2mg/ml) and
safranin O (83·3 nmol/mg), both in the absence and after the
addition of 15, 30 and 45mM-palmitate. Absorbance readings
were transformed into mV membrane potential using the
Nernst equation:
DC ¼ 61 mV·log ð½Kþin=½KþoutÞ:
Calibration curves made for each preparation were obtained
from traces in which the extramitochondrial Kþ level ([Kþ]out)
was altered in the 0·1–20 mM range. The change in absor-
bance caused by the addition of 3mM-valinomycin was plotted
against [Kþ]out. Then, [K
þ]in was estimated by extrapolation of
the line to the zero uptake point.
Western blot quantification of skeletal muscle Akt,
phosphorylated Akt and mitochondrial cytochrome c
Western blot analyses were carried out as described pre-
viously(25). Briefly, skeletal muscle samples were denatured in
a buffer (60·0 mM-Tris, pH 6·8, 10 % sucrose, 2 % SDS and 4 %
b-mercaptoethanol) and loaded onto a 12 % SDS–polyacryl-
amide gel. After the run in electrode buffer (50 mM-Tris, pH
8·3, 384 mM-glycine and 0·1 % SDS), the gels were transferred
onto polyvinylidene difluoride membranes (Immobilon-P;
Millipore) at 0·8 mA/cm2 for 90 min. The membranes were
pre-blocked in blocking buffer (PBS, 5 % milk powder and
0·5 % Tween 20) for 1 h, and then incubated overnight at 48C
with a polyclonal antibody for Akt and phosphorylated
(p)-Akt (diluted 1:1000 in blocking buffer; Cell Signaling) or
with a mouse monoclonal antibody for cytochrome c (diluted
1:100 in blocking buffer; Biomol International). The mem-
branes were washed three times for 12 min in PBS/0·5 %
Tween-20 and three times for 12 min in PBS, and then incu-
bated for 1 h at room temperature with an anti-mouse, alkaline
phosphatase-conjugated secondary antibody (Promega). The
membranes were washed as described above, rinsed in distilled
water and incubated at room temperature with a chemilumi-
nescent substrate (CDP-Star; Sigma-Aldrich). Data detection
was carried out by exposing autoradiography films (Kodak;
Eastman Kodak Company) to the membranes. Quantification
R. Crescenzo et al.1998
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of signals was carried out using Un-Scan-It gel software
(Silk Scientific).
Mitochondrial lipid peroxidation and superoxide
dismutase specific activity
Lipid peroxidation was determined according to Fernandes
et al.(26), by measuring thiobarbituric acid-reactive substances.
Aliquots of mitochondrial suspensions were added to 0·5 ml of
ice-cold 40 % TCA. Then, 2 ml of 0·67 % of aqueous thiobarbi-
turic acid containing 0·01 % of 2,6-di-tert-butyl-p-cresol were
added. The mixtures were heated at 908C for 15 min, then
cooled in ice for 10 min and centrifuged at 850 g for 10 min.
The supernatant fractions were collected and lipid peroxi-
dation was estimated spectrophotometrically at 530 nm. The
amount of thiobarbituric acid-reactive substances formed
was calculated using a molar extinction coefficient of
1·56 £ 105 per M/cm and expressed as nmol thiobarbituric
acid-reactive substances/mg protein. Superoxide dismutase
(SOD) specific activity was measured according to Flohe` &
Otting(27). Determinations were carried out spectrophotometri-
cally (550nm) at 258C in a medium containing 0·1mM-EDTA,
2mM-KCN, 50mM-KH2PO4, pH 7·8, 20mM-cytochrome c,
0·1mM-xanthineand0·01unitsofxanthineoxidase,bymonitoring
the decrease in the reduction rate of cytochrome c by superoxide
radicals, generated by the xanthine–xanthine oxidase system.
One unit of SOD activity is defined as the concentration of the
enzyme that inhibits cytochrome c reduction by 50% in the
presence of xanthine þ xanthine oxidase(27).
Chemicals
All chemicals utilised were of analytical grade and were
purchased from Sigma.
Statistical analysis
Data are provided as means with their standard errors. Statisti-
cal analyses were performed using a two-tailed, unpaired,
Student’s t test or repeated-measures two-way ANOVA for
main effects and interactions followed by Bonferroni’s post-
test. All analyses were performed using GraphPad Prism 4
(GraphPad Software, Inc.).
Results
Body composition measurements carried out at the end of
8 weeks of the dietary treatment show that body energy was
significantly higher in fructose-fed rats than in control rats
(Table 3), due to an increase in energy from lipids but not
in energy from proteins. Cumulative metabolisable energy
intake over the 8 weeks of the dietary treatment was similar
between the two groups (control rats 19 600 (SEM 944) kJ; fruc-
tose-fed rats 19 400 (SEM 453) kJ), thus indicating an increased
metabolic efficiency in fructose-fed rats. As for the skeletal
muscle composition, a significant increase in total lipids,
TAG and ceramide was found in fructose-fed rats compared
with the controls, while no variation was found in cholesterol,
phospholipids and glycogen. Rats fed a fructose-rich diet
exhibited a significant increase in plasma NEFA (Table 3).
The results of the glucose tolerance test carried out in fruc-
tose-fed and control rats at the end of the diet treatment are
presented in Fig. 1. The insulin response was significantly
higher in fructose-fed rats compared with the controls
(Fig. 1(a)), while no significant variation in plasma glucose
levels was found, although the values for fructose-fed rats
tended to be higher than those for control rats (Fig. 1(b)).
Western blot analysis of the p-Akt:Akt ratio in skeletal
muscle from fructose-fed and control rats showed no signifi-
cant variation due to the dietary treatment (Fig. 1(c)). When
p-Akt levels were normalised to insulin plasma levels, signifi-
cantly lower values were found in fructose-fed rats compared
with the controls (Fig. 1(c)). Finally, significantly lower RMR
values were found in fructose-fed rats compared with the con-
trols, starting from week 4 of the dietary treatment (Fig. 1(d)).
Mitochondrial oxidative capacities were assessed in isolated
mitochondria from skeletal muscle using NAD, FAD and lipid
substrates (Table 4) and the results obtained showed no
significant variation in fructose-fed rats compared with the
controls. Mitochondrial protein mass was assessed by measur-
ing homogenate cytochrome c content. The results reported in
Table 4 showed that the cytochrome c:actin ratio was signifi-
cantly higher in fructose-fed rats compared with the controls.
As a consequence, state 3 mitochondrial respiratory rates
assessed in whole-tissue homogenates were found to be sig-
nificantly higher in fructose-fed rats compared with the
controls (Table 4).
Lipid peroxidation and SOD specific activity were measured
and taken as an index of cellular oxidative damage and anti-
oxidant defences, respectively (Table 4). A significant increase
in lipid peroxidation and a significant decrease in SOD activity
were found in fructose-fed rats compared with the controls.
Mitochondrial energetic efficiency was assessed through
the measurement of state 4 respiration in the presence of
Table 3. Energetic and metabolic characterisations in rats fed a
high-fructose or control diet for 8 weeks
(Mean values with their standard errors, n 6 rats per group)
Control Fructose
Mean SEM Mean SEM
Whole-body composition
Final weight (g) 537 31 538 32
Energy (kJ) 4690 252 5227* 288
Lipids (kJ) 2521 130 3042* 150
Proteins (kJ) 2155 112 2209 107
Skeletal muscle composition
Lipids (mg/g) 34·8 0·9 41·2* 1·9
TAG (mg/g) 3·4 0·5 7·0* 0·7
Cholesterol (mg/g) 1·5 0·1 1·4 0·1
Phospholipids (mg/g) 31 2 33 3
Glycogen (mg/g) 1·37 0·05 1·47 0·03
Ceramide (AU/g) 0·018 0·001 0·022* 0·001
Plasma NEFA (mM) 0·41 0·02 0·53* 0·02
AU, absorbance units.
* Mean values were significantly different compared with the controls (P,0·05;
two-tailed, unpaired Student’s t test).
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oligomycin and uncoupled respiration in the presence of
FCCP, as well as through the evaluation of mitochondrial
membrane potential in state 4 conditions, both in the absence
and presence of physiological concentrations of palmitate.
Oligomycin-induced state 4 respiration was significantly
lower, both in the absence and presence of palmitate
(Fig. 2(a)), while maximal FCCP-stimulated respiration was
not affected by high fructose feeding, both in the absence
and presence of palmitate (Fig. 2(b)), so that mitochondrial
efficiency, assessed as the degree of coupling (q), was signifi-
cantly higher in fructose-fed rats compared with the controls,
both in the absence and presence of palmitate (Fig. 2(c)).
Mitochondria from fructose-fed rats were less responsive to
the uncoupling effect of fatty acids, since the mitochondrial
membrane potential in state 4 conditions was found to be sig-
nificantly higher in fructose-fed rats compared with the con-
trols, both in the absence and presence of increasing
concentrations of the fatty acid palmitate (Fig. 2(d)).
Discussion
The main result of the present study is that long-term high
fructose intake in adult rats induces an increase in skeletal
muscle mitochondrial efficiency that could contribute to the
condition of energy sparing (reduced RMR) found here.
First, the present results underline an important role for diet
composition in the induction of obesity and indicate that not
only a high lipid content but also the presence of simple
sugars can affect body energy composition. In fact, despite
the similar metabolisable energy intake during the whole
8-week period, fructose-fed rats exhibited higher body
energy and the increase in body energy was almost exclu-
sively as lipids. Interestingly, a parallel increase in circulating
NEFA and skeletal muscle TAG and ceramide contents was
found in fructose-fed rats. It should be noted that the percen-
tage increase in plasma NEFA and muscle ceramide is similar,
in agreement with previous results in obese human subjects of
a significant correlation between muscle ceramide and plasma
NEFA levels(28).
Rats fed the fructose-rich diet also displayed reduced
whole-body glucose tolerance, with a higher plasma insuli-
naemic response to a glucose load, results that are similar to
those previously obtained in rats fed a high-fat diet(29). Since
glucose buffering capacity after a glucose load is primarily
determined by the skeletal muscle metabolic response to insu-
lin, downstream target of the insulin signalling pathway in the
skeletal muscle of fructose-fed rats was investigated, and
no difference was found in p-Akt kinase levels, but when
the p-Akt kinase levels were normalised to plasma insulin
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Fig. 1. Plasma (a) insulin and (b) glucose levels after a glucose load ( , control; , fructose), (c) Western blot quantification of phosphorylated
(p)-Akt:Akt levels and p-Akt:plasma insulin levels in skeletal muscle and (d) time course of RMR in fructose-fed ( ) or control ( ) rats. Values are means (n 6 rats
per group), with their standard errors represented by vertical bars. AUC was calculated using the trapezoid method. * Mean values were significantly different
compared with the controls (P,0·05; two-tailed, unpaired Student’s t test for insulin AUC and p-Akt, repeated-measures two-way ANOVA for main effects and
interactions followed by Bonferroni’s post-test for RMR).
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concentrations, significantly lower values were found in fruc-
tose-fed rats compared with the controls. This result is in
agreement with increased skeletal muscle ceramide content,
since it is well known that ceramide has been identified as
a key mediator of insulin resistance via inhibition of Akt phos-
phorylation(30), and indicates that insulin action is blunted in
skeletal muscle from fructose-fed rats. However, this impair-
ment is compensated by higher plasma insulin, so that the
Table 4. Mitochondrial oxidative capacities, mass and oxidative status in skeletal muscle from rats fed a high-fructose or
control diet for 8 weeks
(Mean values with their standard errors, n 6 rats per group)
Control Fructose
Mean SEM Mean SEM
State 3 respiration in isolated mitochondria (ng atoms O/(min £ mg protein))
Glutamate þ malate 846 55 861 55
Succinate þ rotenone 815 66 888 97
Palmitoyl-CoA þ carnitine þ malate 341 28 365 23
Palmitoyl-carnitine þ malate 304 15 348 22
Pyruvate þ malate 788 41 819 60
State 3 respiration in whole-tissue homogenate (ng atoms O/(min £ g wet tissue))
Glutamate þ malate 3963 333 5456* 451
Succinate þ rotenone 4172 337 5305* 217
Palmitoyl-CoA þ carnitine þ malate 1971 141 2474* 136
Palmitoyl-carnitine þ malate 1521 120 2013* 169
Pyruvate þ malate 4429 276 5723* 339
Mitochondrial mass
Cytochrome c:actin ratio 2·78 0·15 3·40* 0·15
Mitochondrial oxidative status
Lipid peroxidation (nmol thiobarbituric acid-reactive substances/mg protein) 4·99 0·25 5·93* 0·30
Superoxide dismutase activity (U/mg protein) 85·1 6·0 59·2* 6·0
* Mean values were significantly different compared with the controls (P,0·05; two-tailed, unpaired Student’s t test).
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final response of skeletal muscle cells to insulin is maintained.
In agreement with this finding, tissue glycogen content does
not vary in fructose-fed rats compared with the controls, in
line with the well-known positive regulatory role of insulin
in glycogen synthesis in this tissue(31).
Whole-body insulin resistance is usually associated with
alterations in the metabolic activity of skeletal muscle, and
derangement in mitochondrial performance in skeletal
muscle has been correlated with the development of insulin
resistance(32). Other studies have indicated that insulin resist-
ance can be dissociated from mitochondrial respiratory
capacity. Thus, in rat studies where the animals were given
a high-fat diet, insulin resistance develops along with an
increase in mitochondrial content and an increase in the
capacity to oxidise fat(33–36). Mitochondrial content inside
the cell and oxidative phosphorylation efficiency are the
main determinants of mitochondrial performance. Oxidative
phosphorylation efficiency depends on the degree of coupling
between oxygen consumption and ATP synthesis, which is
always lower than 1 and can vary according to the metabolic
needs of the cell(11). It is well known that fatty acids can act as
natural uncouplers of oxidative phosphorylation(37). There-
fore, mitochondrial mass and the degree of coupling, as well
as the uncoupling effect of the fatty acid palmitate were
assessed. The present results show that in fructose-fed rats,
skeletal muscle mitochondrial mass increases, in agreement
with the increased mitochondrial protein synthesis rate
found in rats fed a high-fructose diet(38). This increase in mito-
chondrial mass could be a compensatory mechanism to the
increased fatty acid supply due to higher plasma NEFA
levels found here, since it has been shown that raising
plasma NEFA levels induces increased mitochondrial biogen-
esis in skeletal muscle(39). However, the compensatory
increase in mitochondrial mass probably failed to buffer
NEFA oversupply, due to the increased mitochondrial coup-
ling found in rats fed a fructose-rich diet, since in this
condition, less amount of fuels are oxidised to obtain the
same amount of ATP. Decreased substrate burning by skeletal
muscle is supported by the decrease in RMR found here
in fructose-fed rats compared with the controls, given that
skeletal muscle accounts for about 30 % of whole-body
energy expenditure(40). The failure of the mitochondrial
compartment to face with the increased supply of lipid sub-
strates in fructose-fed rats is also in agreement with their
significantly higher skeletal muscle TAG, which imply an
increase in intramuscular adipose tissue deposition. Intramus-
cular adipose tissue enlargement is considered among the
determinants of insulin resistance(41), through diacylglycerol
and ceramide accumulation inside the skeletal muscle cells(42).
Another unwanted consequence of the increased degree
of coupling is higher mitochondrial free radical production
(reactive oxygen species). In fact, the production of reactive
oxygen species by the mitochondrial respiratory chain is
higher when the membrane potential increases(43,44), and
reactive oxygen species production is indicated as one of
the potential causes leading to insulin resistance(45,46). For
these reasons, the oxidative status of skeletal muscle
mitochondria was also assessed and, in fructose-fed rats,
signs of oxidative damage were found, together with the
decreased activity of SOD, one of the enzymatic components
of the antioxidant defence system. These results are in agree-
ment with the impairment in insulin action found in this tissue,
since it has recently been shown that the overexpression
of mitochondrial SOD in skeletal muscle from rats fed a
high-fat diet ameliorated the reduction in muscle glucose
uptake and that this effect was mediated through an altered
redox state(47).
In conclusion, the present results give evidence that a fruc-
tose-rich diet has a deep impact not only on liver tissue, which
is responsible for about 90 % of fructose metabolism, but also
on another metabolically relevant tissue, the skeletal muscle.
In this tissue, the consequences of high fructose feeding are
decreased insulin signalling, stimulated mitochondrial bio-
genesis and increased mitochondrial coupling. This latter
modification could have a detrimental metabolic effect by
causing energy sparing that contributes to the high metabolic
efficiency of fructose-fed rats.
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